Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
The safety and efficacy of a minimally interrupted novel oral anticoagulant (NOAC) strategy at the time of atrial fibrillation (AF) ablation is uncertain. The purpose of this study was to compare rates of bleeding and thromboembolic events between minimally interrupted NOAC and uninterrupted vitamin...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2018
|
| Sorozat: | JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
53 No. 3 |
| Tárgyszavak: | |
| doi: | 10.1007/s10840-018-0417-0 |
| mtmt: | 34106023 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28092 |